Cite
HARVARD Citation
Lee, K. et al. (n.d.). 38OTalazoparib (TALA) vs physician's choice of chemotherapy (PCT) in Asian patients (Pts) with HER2- advanced breast cancer (ABC) and a germline BRCA1/2 mutation (gBRCA1/2mut): Data from phase III EMBRACA. Annals of oncology. p. . [Online].